1 study found for:    NCT01866826
Show Display Options
Rank Status Study
1 Recruiting Rifaximin for Chronic Immune Activation in People With HIV
Conditions: HIV;   RIFAXIMIN
Interventions: Drug: Rifaximin;   Drug: Placebo

Indicates status has not been verified in more than two years